Does LYPRESSIN Cause Chronic obstructive pulmonary disease? 35 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 35 reports of Chronic obstructive pulmonary disease have been filed in association with LYPRESSIN. This represents 54.7% of all adverse event reports for LYPRESSIN.
35
Reports of Chronic obstructive pulmonary disease with LYPRESSIN
54.7%
of all LYPRESSIN reports
35
Deaths
33
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From LYPRESSIN?
Of the 35 reports, 35 (100.0%) resulted in death, 33 (94.3%) required hospitalization, and 31 (88.6%) were considered life-threatening.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LYPRESSIN. However, 35 reports have been filed with the FAERS database.
What Other Side Effects Does LYPRESSIN Cause?
Abdominal distension (51)
Vomiting (51)
Abdominal pain (50)
Appendicitis (50)
Ascites (50)
Condition aggravated (50)
Hyponatraemia (50)
Off label use (50)
Sepsis (50)
Somnolence (50)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)